Fri 6 Nov 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Strength | Doesage Form | Price | Details |
|---|---|---|---|---|---|
| CEFTRIAXONE | CefTRIAXone | 1 | Powder and solvent for solution for injection | 21.00 | Details |
| CEFTRIAXONE | Ceftriaxone Venus | 1 | Powder for solution for injection/infusion | 19.15 | Details |
| TIBOLONE | TiboFem | 2.5 | Tablet | 60.30 | Details |
| CEFDINIR | Omnicef 250mg/5ml Suspension | 50 | Oral suspension | 101.20 | Details |
| DESLORATADINE | Batlor | 0.5 | Syrup | 11.45 | Details |
| DAPOXETINE | TALYNTA | 60 | Film-coated tablet | 49 | Details |
| DAPOXETINE | TALYNTA | 30 | Film-coated tablet | 49 | Details |
| DESLORATADINE | Lorius | 5 | Film-coated tablet | 16.75 | Details |
| DESLORATADINE | Lorius | 5 | Film-coated tablet | 5.60 | Details |
| FEBUXOSTAT | Zoxta | 80 | Film-coated tablet | 63.60 | Details |
| FEBUXOSTAT | Zoxta | 40 | Film-coated tablet | 63.60 | Details |
| CASPOFUNGIN ACETATE | Kanvasiv | 50 | Powder for concentrate for solution for infusion | 518.15 | Details |
| CASPOFUNGIN ACETATE | Kanvasiv | 70 | Powder for concentrate for solution for infusion | 663.85 | Details |
| IBUPROFEN | Prof | 400 | Solution for infusion | 33 | Details |
| TADALAFIL | Dandaxa | 20 | Film-coated tablet | 15.85 | Details |
| METRONIDAZOLE | NEGAZOLE | 250 | Film-coated tablet | 26 | Details |
| CLARITHROMYCIN | CLARIDAR XL 500 mg Tablet | 500 | Prolonged-release tablet | 57.15 | Details |
| METFORMIN HYDROCHLORIDE | Glucophage XR | 1000 | Prolonged-release tablet | 33.35 | Details |
| CARBIMAZOLE | Carbimazole Macleods | 5 | Tablet | 20.75 | Details |
| REMDESIVIR | Veklury | 100 | Powder for concentrate for solution for infusion | 1769.65 | Details |
11.43% of users said yes from 315 Response.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.